tiprankstipranks
NioCorp Developments Ltd (NIOBF)
OTHER OTC:NIOBF

NioCorp Developments (NIOBF) Income Statement

0 Followers

NioCorp Developments Income Statement

Last quarter (Q ), NioCorp Developments's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q, NioCorp Developments's net income was $-2.21M. See NioCorp Developments’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jun 22Jun 21Jun 20Jun 19Jun 18
Total Revenue
-$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 7.79M$ 7.80M$ 4.09M$ 3.43M$ 6.44M$ 6.04M
Operating Income
$ -7.79M$ -7.80M$ -4.09M$ -3.43M$ -6.44M$ -6.04M
Net Non Operating Interest Income Expense
$ -2.23M$ -2.83M$ -1.11M$ -354.00K$ -266.00K$ -375.00K
Other Income Expense
$ -207.00K$ -264.00K$ 815.00K$ -215.00K$ -634.00K$ -2.09M
Pretax Income
$ -10.23M$ -10.89M$ -4.39M$ -4.00M$ -7.34M$ -8.50M
Tax Provision
-$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -10.23M$ -10.89M$ -4.39M$ -4.00M$ -7.34M$ -8.50M
Basic EPS
$ -0.03-$ -0.02$ -0.02$ -0.03$ -0.04
Diluted EPS
$ -0.03-$ -0.02$ -0.02$ -0.03$ -0.04
Basic Average Shares
$ 813.45M-$ 241.97M$ 234.61M$ 223.16M$ 207.26M
Diluted Average Shares
$ 813.45M-$ 241.97M$ 234.61M$ 223.16M$ 207.26M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 7.79M$ 7.80M$ 4.09M$ 3.43M$ 6.44M$ 6.04M
Interest Expense
$ 2.23M$ 2.83M$ 1.11M$ 354.00K$ 266.00K$ 375.00K
Net Income From Continuing And Discontinued Operation
$ -10.23M$ -10.89M$ -4.39M$ -4.00M$ -7.34M$ -8.50M
Normalized Income
$ -10.02M$ -10.62M$ -5.00M$ -3.79M$ -6.70M$ -6.41M
EBIT
$ -8.00M$ -8.06M$ -3.28M$ -3.65M$ -7.07M$ -8.12M
EBITDA
$ -8.00M$ -8.06M$ -3.28M$ -3.65M$ -7.07M$ -8.12M
Currency in USD

NioCorp Developments Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis